In 133 patients with IDC, the TNF-α genotype failed to predict either the severity of pump dysfunction and cardiac dilatation at baseline, or changes in pump function and cardiac dimensions after six months of medical treatment. This evidence concerns the gene TNF and Vascular dilatation.